(2S)-3-methyl-2-phenyl-5-phenylsulfanyl-1-prop-2-enyl-2,4-dihydropyrimido[4,5-d]pyrimidine
C22H22N4S — CID 139063960
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-3-methyl-2-phenyl-5-phenylsulfanyl-1-prop-2-enyl-2,4-dihydropyrimido[4,5-d]pyrimidine
(2S)-3-methyl-2-phenyl-5-phenylsulfanyl-1-prop-2-enyl-2,4-dihydropyrimido[4,5-d]pyrimidine (PubChem CID 139063960) has the molecular formula C22H22N4S and a molecular weight of 374.51 g/mol. Its IUPAC name is (2S)-3-methyl-2-phenyl-5-phenylsulfanyl-1-prop-2-enyl-2,4-dihydropyrimido[4,5-d]pyrimidine.
Molecular Properties
| Compound Name | (2S)-3-methyl-2-phenyl-5-phenylsulfanyl-1-prop-2-enyl-2,4-dihydropyrimido[4,5-d]pyrimidine |
|---|---|
| PubChem CID | 139063960 |
| Molecular Formula | C22H22N4S |
| Molecular Weight | 374.51 g/mol |
| Exact Mass | 374.16 |
| IUPAC Name | (2S)-3-methyl-2-phenyl-5-phenylsulfanyl-1-prop-2-enyl-2,4-dihydropyrimido[4,5-d]pyrimidine |
| SMILES | C=CCN1c2ncnc(Sc3ccccc3)c2CN(C)[C@@H]1c1ccccc1 |
| InChI | InChI=1S/C22H22N4S/c1-3-14-26-20-19(15-25(2)22(26)17-10-6-4-7-11-17)21(24-16-23-20)27-18-12-8-5-9-13-18/h3-13,16,22H,1,14-15H2,2H3/t22-/m0/s1 |
| InChIKey | XIGOUWOBTVUQRI-QFIPXVFZSA-N |
| XLogP | 4.76 |
| TPSA | 32.26 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 374.51 |
| LogP ≤ 5 | 4.76 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139063960 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.